Skip to content

Internet-administrated Treatment of Anxiety Symptoms for Young Adults

Tailored Internet-administrated Treatment of Anxiety Symptoms for Young Adults

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT01402258
Acronym
NOVA-IV
Enrollment
15
Registered
2011-07-26
Start date
2011-04-30
Completion date
2015-06-30
Last updated
2023-12-14

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Anxiety Disorders, Depression

Brief summary

The purpose of this study is to determine whether tailored internet-administrated CBT is a feasible approach in the treatment of anxiety symptoms and comorbid anxiety and depressive symptoms in a clinical setting.

Interventions

This intervention contains 6-8 text-based self-help modules in which 4 modules are fixed (the first three and the last) and the rest are prescribed following the diagnostic telephone interview. These modules contain material on panic disorder, social phobia, stress management, assertiveness training, concentration, relaxation among other things.

Sponsors

Linkoeping University
Lead SponsorOTHER_GOV

Study design

Allocation
NA
Intervention model
SINGLE_GROUP
Primary purpose
TREATMENT
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
16 Years to 25 Years
Healthy volunteers
No

Inclusion criteria

* Be between the ages of 16-25 years old * Have anxiety symptoms and/or anxiety syndrome

Exclusion criteria

* Suicide prone * Alcohol addiction * Ongoing psychological treatment

Design outcomes

Primary

MeasureTime frameDescription
Beck Anxiety Inventory (BAI)- Change from baselineTwo weeks pre treatment, two weeks post treatment, six months and 12 months post treatmentChange from baseline in anxiety symptoms two weeks post treatment, at six months and at 12 months post treatment.

Secondary

MeasureTime frameDescription
Quality of Life Inventory (QOLI)- Change from baselineTwo weeks pre treatment, two weeks post treatment, six months and 12 months post treatmentChange from baseline in quality of life statements two weeks post treatment, at six months and at 12 months post treatment.
Montgomery Åsberg Depression Rating Scale-Self Rated (MADRS-S)- Change from baselineTwo weeks pre treatment, two weeks post treatment, six months and 12 months post treatmentChange from baseline in depressive symptoms two weeks post treatment, at six months and at 12 months post treatment.
Clinical Outcome in Routine Evaluation - Outcome Measure (CORE-OM)- Change from baselineTwo weeks pre treatment, two weeks post treatment, six months and 12 months post treatmentChange from baseline in anxiety and depressive symptoms two weeks post treatment, at six months and at 12 months post treatment.

Countries

Sweden

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026